腹主动脉瘤合并V型马蹄肾的腔内主动脉修复术
本文报告一例70岁男性腹主动脉瘤(57.8 mm×54.3 mm)合并V型马蹄肾,由肠系膜下动脉发出的4.4 mm肾峡部动脉和主动脉分叉发出的4.6 mm肾峡部动脉供血。采用腔内主动脉修复术(EVAR)联合潜望镜支架与栓塞治疗,1年随访动脉瘤消退、马蹄肾灌注良好,无内漏,血肌酐未升高。作者认为EVAR为合并V型马蹄肾的腹主动脉瘤提供了可行选择,尤其适用于高手术风险患者。
要点
- 合并V型马蹄肾的腹主动脉瘤需保留供血比例大的肾峡部动脉。
- EVAR联合潜望镜支架与栓塞可用于此类高手术风险患者。
- 1年随访动脉瘤消退、马蹄肾灌注良好、无内漏、血肌酐未升高。
核心结论
- 采用EVAR为合并V型马蹄肾的腹主动脉瘤提供了可行选择,尤其适用于高手术风险病例。
研究设计与样本
- 病例报告:1例70岁男性腹主动脉瘤(57.8 mm×54.3 mm)合并V型马蹄肾,接受EVAR联合潜望镜支架与栓塞治疗。
主要发现
- 马蹄肾由肠系膜下动脉发出的4.4 mm肾峡部动脉和主动脉分叉发出的4.6 mm肾峡部动脉供血。
- 1年随访动脉瘤消退,马蹄肾保持灌注,无内漏,血肌酐水平未升高。
临床怎么用
- 当开放手术不可行时,EVAR联合潜望镜支架与栓塞为合并V型马蹄肾的腹主动脉瘤高手术风险患者提供了可行治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Abdominal aortic aneurysm (AAA) with concomitant Horseshoe kidney (HSK) is rare. When open surgery is not feasible, preserving the renal isthmus artery (RIA) during endovascular treatment presents a challenge. CASE REPORT: A 70-year-old male presented with a 57.8 mm × 54.3 mm AAA and type V HSK perfused by a 4.4 mm RIA from the inferior mesenteric artery and a 4.6 mm RIA from the aortic bifurcation. This case report describes an endovascular aortic aneurysm repair (EVAR) performed on an AAA coexisting with a type V HSK. One-year follow-up: the AAA had regressed, and the HSK remained perfused without any endoleak or increase in serum creatinine levels. CONCLUSION: The utilization of EVAR offers a feasible option for AAA combined with type V HSK, particularly in cases of high surgical risk. CLINICAL IMPACT: In Abdominal aortic aneurysm (AAA) with type V horseshoe kidney (HSK), preserving renal isthmus arteries (RIAs) is critical when they provide a substantial portion of the HSK blood supply.When open surgery is not feasible, preserving the RIA during endovascular treatment presents a challenge.The use of EVAR, incorporating a periscope stent and embolization, provides a viable treatment option for patients with AAA and type V HSK, especially in high surgical risk cases.
引用
- Wu M, Xiong J. Endovascular Aortic Aneurysm Repair for Abdominal Aortic Aneurysm With Type V Horseshoe Kidney. J Endovasc Ther. 2025. PMID: 39902665. doi:10.1177/15266028251316136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。